SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-24-008015
Filing Date
2024-01-30
Accepted
2024-01-30 17:26:20
Documents
16
Period of Report
2024-01-30
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea192430-8k_cormedix.htm   iXBRL 8-K 24832
2 PRESS RELEASE DATED JANUARY 30, 2024 ea192430ex99-1_cormedix.htm EX-99.1 12774
3 GRAPHIC ex99-1_001.jpg GRAPHIC 18675
  Complete submission text file 0001213900-24-008015.txt   240712

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE crmd-20240130.xsd EX-101.SCH 3015
5 XBRL LABEL FILE crmd-20240130_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE crmd-20240130_pre.xml EX-101.PRE 22359
17 EXTRACTED XBRL INSTANCE DOCUMENT ea192430-8k_cormedix_htm.xml XML 3602
Mailing Address 300 CONNELL DRIVE SUITE 4200 BERKELEY HEIGHTS NJ 07922
Business Address 300 CONNELL DRIVE SUITE 4200 BERKELEY HEIGHTS NJ 07922 908-517-9500
CorMedix Inc. (Filer) CIK: 0001410098 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34673 | Film No.: 24579703
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)